US Stock MarketDetailed Quotes
TXG 10x Genomics
- 14.310
- +1.020+7.67%
Close Nov 22 16:00 ET
- 14.500
- +0.190+1.33%
Post 20:02 ET
1.73BMarket Cap-9414P/E (TTM)
14.565High12.980Low5.63MVolume13.170Open13.290Pre Close79.88MTurnover5.37%Turnover RatioLossP/E (Static)121.05MShares57.90052wk High2.40P/B1.50BFloat Cap12.95052wk Low--Dividend TTM104.96MShs Float208.990Historical High--Div YieldTTM11.93%Amplitude12.950Historical Low14.184Avg Price1Lot Size
10x Genomics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.30%151.65M | 4.28%153.1M | 5.01%141.01M | 19.81%618.73M | 17.76%183.98M | 17.22%153.64M | 28.10%146.82M | 17.28%134.29M | 5.28%516.41M | 8.85%156.23M |
| Operating revenue | -1.30%151.65M | 4.28%153.1M | 5.01%141.01M | 19.81%618.73M | 17.76%183.98M | 17.22%153.64M | 28.10%146.82M | 17.28%134.29M | 5.28%516.41M | 8.85%156.23M |
| Cost of revenue | -22.12%45.26M | 3.55%48.88M | 33.98%48.09M | 73.95%209.41M | 85.18%68.2M | 91.31%58.12M | 70.40%47.21M | 40.89%35.9M | 62.48%120.39M | 33.44%36.83M |
| Gross profit | 11.37%106.39M | 4.63%104.22M | -5.57%92.91M | 3.36%409.31M | -3.03%115.78M | -5.13%95.53M | 14.62%99.61M | 10.53%98.39M | -4.89%396.02M | 3.00%119.41M |
| Operating expense | -0.70%147.88M | -10.44%145.96M | 2.68%154.41M | 8.81%613.66M | 6.24%151.39M | 5.85%148.92M | 8.63%162.97M | 15.01%150.38M | 20.17%563.97M | 8.15%142.5M |
| Selling and administrative expenses | -0.86%81.7M | -9.26%83.04M | 2.99%85.77M | 15.10%343.33M | 9.18%86.13M | 12.28%82.42M | 15.34%91.51M | 24.90%83.28M | 15.82%298.3M | 12.89%78.89M |
| Research and development costs | -0.50%66.17M | -11.95%62.92M | 2.30%68.64M | 1.76%270.33M | 2.60%65.27M | -1.16%66.51M | 1.10%71.46M | 4.71%67.1M | 25.46%265.67M | 2.79%63.61M |
| Operating profit | 22.30%-41.49M | 34.13%-41.74M | -18.29%-61.5M | -21.68%-204.35M | -54.18%-35.61M | -33.50%-53.39M | -0.38%-63.36M | -24.57%-51.99M | -217.40%-167.94M | -45.90%-23.1M |
| Net non-operating interest income expense | 15.59%4.97M | 15.12%4.71M | 22.99%4.74M | 173.42%16.87M | 72.08%4.63M | 124.96%4.3M | 262.71%4.1M | 773.02%3.85M | 1,035.00%6.17M | 1,701.19%2.69M |
| Non-operating interest income | 15.60%4.97M | 15.00%4.72M | 22.41%4.74M | 154.34%16.91M | 64.72%4.64M | 112.35%4.3M | 231.18%4.1M | 579.96%3.87M | 3,126.70%6.65M | 5,644.90%2.82M |
| Non-operating interest expense | 100.00%2K | -80.00%1K | -94.74%1K | -93.07%33K | -93.60%8K | -99.12%1K | -95.41%5K | -85.16%19K | -45.03%476K | -42.40%125K |
| Other net income (expense) | 104.87%2.08M | 96.28%-56K | 31.40%-1.04M | -30,853.03%-61.29M | -490.91%-15.62M | -2,087.18%-42.65M | 18.39%-1.5M | -279.00%-1.52M | -39.44%-198K | 79,800.00%4M |
| Special income (charges) | --0 | ---- | ---- | ---60.98M | ---19.58M | ---41.4M | ---- | ---- | --0 | --0 |
| -Less：Restructuring and merger&acquisition | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | --60.98M | --19.58M | --41.4M | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | 266.51%2.08M | 96.28%-56K | 31.40%-1.04M | -55.05%-307K | -0.85%3.96M | 36.00%-1.25M | 18.39%-1.5M | -279.00%-1.52M | 75.31%-198K | 79,800.00%4M |
| Income before tax | 62.46%-34.44M | 38.98%-37.08M | -16.41%-57.8M | -53.58%-248.76M | -183.94%-46.6M | -129.16%-91.74M | 4.80%-60.77M | -19.09%-49.65M | -201.54%-161.97M | -2.61%-16.41M |
| Income tax | 5.88%1.32M | -50.33%818K | 96.34%2.15M | 57.26%6.34M | 192.79%2.35M | -33.90%1.24M | 162.68%1.65M | 52.02%1.09M | -10.63%4.03M | -67.26%804K |
| Net income | 61.55%-35.75M | 39.28%-37.9M | -18.13%-59.95M | -53.67%-255.1M | -184.36%-48.95M | -121.85%-92.99M | 3.17%-62.41M | -19.65%-50.75M | -185.11%-166M | 6.69%-17.22M |
| Net income continuous Operations | 61.55%-35.75M | 39.28%-37.9M | -18.13%-59.95M | -53.67%-255.1M | -184.36%-48.95M | -121.85%-92.99M | 3.17%-62.41M | -19.65%-50.75M | -185.11%-166M | 6.69%-17.22M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 61.55%-35.75M | 39.28%-37.9M | -18.13%-59.95M | -53.67%-255.1M | -184.36%-48.95M | -121.85%-92.99M | 3.17%-62.41M | -19.65%-50.75M | -185.11%-166M | 6.69%-17.22M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 61.55%-35.75M | 39.28%-37.9M | -18.13%-59.95M | -53.67%-255.1M | -184.36%-48.95M | -121.85%-92.99M | 3.17%-62.41M | -19.65%-50.75M | -185.11%-166M | 6.69%-17.22M |
| Basic earnings per share | 62.03%-0.3 | 39.62%-0.32 | -13.64%-0.5 | -49.32%-2.18 | -173.33%-0.41 | -113.51%-0.79 | 7.02%-0.53 | -15.79%-0.44 | -175.47%-1.46 | 6.25%-0.15 |
| Diluted earnings per share | 62.03%-0.3 | 39.62%-0.32 | -13.64%-0.5 | -49.32%-2.18 | -173.33%-0.41 | -113.51%-0.79 | 7.02%-0.53 | -15.79%-0.44 | -175.47%-1.46 | 6.25%-0.15 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data